Skip to content
Intended for US healthcare professionals.

Therapeutic area

Nephrology

1 article · 7 references

Autosomal dominant polycystic kidney disease: risk and progression after the 2025 KDIGO guideline KDIGO's first ADPKD guideline anchors risk on the Mayo Imaging Classification; 10-year kidney failure ran from 2.4% in subclass 1A to 66.9% in 1E in the Mayo Clinic cohort that defined it, and from 2.2% in 1C to 22.3% in 1E in a younger validation cohort. 4 min read · 7 references
Other therapeutic areas
Opioid-induced constipation 2 articlesAcute migraine 2 articlesAcute pain 2 articlesMusculoskeletal 3 articlesWomen's health & fertility 3 articlesOncology 3 articlesCardiovascular & vascular 1 articleEndocrinology & metabolism 1 articleMental & behavioral health 1 article
We use cookies on this site
We use essential cookies to make the site work, and — only with your consent — analytics cookies to see which clinical topics are read. See our Cookie Policy.
Manage preferences